Blanc, F., Sok, T., Laureillard, D., Borand, L., Rekacewicz, C., Nerrienet, E., . . . Goldfeld, A. E. (2011). Early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) significantly enhance survival of severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: Results of the CAMELIA clinical trial. BioMed Central.
শিকাগো স্টাইলে সাইটেশনBlanc, François-Xavier, et al. Early (2 Weeks) Vs. Late (8 Weeks) Initiation of Highly Active Antiretroviral Treatment (HAART) Significantly Enhance Survival of Severely Immunosuppressed HIV-infected Adults With Newly Diagnosed Tuberculosis: Results of the CAMELIA Clinical Trial. BioMed Central, 2011.
এমএলএ সাইটেশনBlanc, François-Xavier, et al. Early (2 Weeks) Vs. Late (8 Weeks) Initiation of Highly Active Antiretroviral Treatment (HAART) Significantly Enhance Survival of Severely Immunosuppressed HIV-infected Adults With Newly Diagnosed Tuberculosis: Results of the CAMELIA Clinical Trial. BioMed Central, 2011.